Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis ; volume:14 ; number:4 ; day:17 ; month:8 ; year:2012 ; pages:1-9 ; date:8.2012
Arthritis Research & Therapy ; 14, Heft 4 (17.8.2012), 1-9, 8.2012
- Urheber
-
Kim, Jeong Yeon
- Beteiligte Personen und Organisationen
-
Lee, Eun Young
Lee, Eun Bong
Lee, Yun Jong
Yoo, Hyun Jung
Choi, Jiyong
Song, Yeong Wook
SpringerLink (Online service)
- DOI
-
10.1186/ar4018
- URN
-
urn:nbn:de:1111-2016050323276
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Jeong Yeon
- Lee, Eun Young
- Lee, Eun Bong
- Lee, Yun Jong
- Yoo, Hyun Jung
- Choi, Jiyong
- Song, Yeong Wook
- SpringerLink (Online service)
Ähnliche Objekte (12)
Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis
Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis
Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis
Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis
Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis
Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis
Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis
Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis